Evidence map›Paper›PMID 32144204›Full record

ArticleThe Journal of biological chemistry2020

Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Hisako Akiyama, Mitsuko Ide, Yasuko Nagatsuka, Tomoko Sayano, Etsuro Nakanishi, Norihito Uemura, Kohei Yuyama, Yoshiki Yamaguchi, Hiroyuki Kamiguchi, Ryosuke Takahashi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Sterylglucosides in Fungi.Journal of fungi (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hisako AkiyamaRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Mitsuko IdeRIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Cellular Informatics Laboratory, RIKEN, Wako, Saitama 351-0198, Japan.
Yasuko NagatsukaRIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Tomoko SayanoRIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Etsuro NakanishiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Norihito UemuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Kohei YuyamaLipid Biofunction Section, Faculty of Advanced Life Science, Hokkaido University, Sapporo, Hokkaido 001-0021, Japan.
Yoshiki YamaguchiLaboratory of Pharmaceutical Physical Chemistry, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan.
Hiroyuki KamiguchiRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Ryosuke TakahashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
Johannes M F G AertsDepartment of Medical Biochemistry, Leiden Institute of Chemistry, Leiden 2333 CC, The Netherlands.
Peter GreimelRIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan.
Yoshio HirabayashiRIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Cellular Informatics Laboratory, RIKEN, Wako, Saitama 351-0198, Japan. Electronic address: hirabaya@riken.jp.
RIKEN Center for Brain Science · JPKyoto University · JPHokkaido University · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Glucocerebrosidase (GBA) hydrolyzes glucosylceramide (GlcCer) to generate ceramide. Previously, we demonstrated that lysosomal GBA1 and nonlysosomal GBA2 possess not only GlcCer hydrolase activity, but also transglucosylation activity to transfer the glucose residue from GlcCer to cholesterol to form β-cholesterylglucoside (β-GlcChol)

Indexed as

AnimalsBrainCell Line, TumorCells, CulturedCholesterolFemaleGalactoseGalactosylceramidesGlucosylceramidaseHumansMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred ICRMyelin SheathCholesterolGalactoseGalactosylceramidesgalactosylcholesterolGlucosylceramidasebraincholesterolgalactosylated cholesterolglucocerebrosidaseglycolipidmass spectrometry (MS)sterolsterylglycosidetransglycosylationβ-cholesterylgalactoside

Identifiers

PMID32144204
PMCPMC7170530
OpenAlexW3009770495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.